{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T03:39:27Z","timestamp":1793936367796,"version":"4.8.0"},"reference-count":145,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2009,6,15]],"date-time":"2009-06-15T00:00:00Z","timestamp":1245024000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2009,9]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>As the cure rates for haematological malignancies have improved, the exploration of the balance between efficacy and side effects has become a major research target. The antifolate methotrexate is widely used in the treatment of acute lymphoblastic leukaemia, non\u2010Hodgkin lymphoma, and osteosarcoma. Even when given identical methotrexate doses, patients vary significantly in their response and pattern of toxicities. This diversity can, to some extent, be linked to sequence variations in genes involved in drug absorption, metabolism, excretion, cellular transport, and effector targets or target pathways. In the coming years pharmacogenomics is expected to change our approaches to individualised therapy with methotrexate. However, genetic polymorphisms affect the pharmacokinetics and dynamics of all the drugs a patient receive as well as the normal tissues tolerance to a given drug exposure. Thus, although high\u2010throughput techniques will allow mapping of tens of thousands of genetic polymorphisms in one run, it will be a major challenge to dissect out which of these have the strongest impact on efficacy and toxicity and hence should be the targets for intervention. This paper discusses the pharmacology of methotrexate and reviews studies on haematological malignancies that have attempted to predict the risk of toxicity by specific clinical or genetic features.<\/jats:p>","DOI":"10.1111\/j.1365-2141.2009.07765.x","type":"journal-article","created":{"date-parts":[[2009,6,16]],"date-time":"2009-06-16T01:54:22Z","timestamp":1245117262000},"page":"489-503","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":208,"title":["Advances in individual prediction of methotrexate toxicity: a review"],"prefix":"10.1111","volume":"146","author":[{"given":"Kjeld","family":"Schmiegelow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,8,11]]},"reference":[{"key":"e_1_2_27_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1651-2227.1998.tb01399.x"},{"key":"e_1_2_27_3_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-04-2606"},{"key":"e_1_2_27_4_1","first-page":"2342","article-title":"Pharmacokinetics of oral methotrexate in children","volume":"43","author":"Balis F.M.","year":"1983","journal-title":"Cancer Research"},{"key":"e_1_2_27_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1987.45"},{"key":"e_1_2_27_6_1","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1182\/blood.V84.2.564.564","article-title":"Differences in constitutive and post\u2010methotrexate folylpolyglutamate synthetase activity in B\u2010lineage and T\u2010lineage leukemia","volume":"84","author":"Barredo J.C.","year":"1994","journal-title":"Blood"},{"key":"e_1_2_27_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-291X(73)90949-2"},{"key":"e_1_2_27_8_1","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1182\/blood.V93.5.1643","article-title":"Reduced folate carrier expression in acute lymphoblastic leukemia: a mechanism for ploidy but not lineage differences in methotrexate accumulation","volume":"93","author":"Belkov V.M.","year":"1999","journal-title":"Blood"},{"key":"e_1_2_27_9_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1991.70"},{"key":"e_1_2_27_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)90464-6"},{"key":"e_1_2_27_11_1","first-page":"203","article-title":"\u201cRescue\u201d techniques in cancer chemotherapy: use of leucovorin and other rescue agents after methotrexate treatment","volume":"4","author":"Bertino J.R.","year":"1977","journal-title":"Seminars in Oncology"},{"key":"e_1_2_27_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/mpo.2950230208"},{"key":"e_1_2_27_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197801)41:1<36::AID-CNCR2820410108>3.0.CO;2-I"},{"issue":"1","key":"e_1_2_27_14_1","first-page":"89","article-title":"Neurologic sequelae of methotrexate and ionizing radiation: a new classification","volume":"65","author":"Bleyer W.A.","year":"1981","journal-title":"Cancer Treatment Reports"},{"key":"e_1_2_27_15_1","doi-asserted-by":"publisher","DOI":"10.1097\/00043426-199711000-00008"},{"key":"e_1_2_27_16_1","doi-asserted-by":"publisher","DOI":"10.1358\/dnp.2007.20.10.1181353"},{"key":"e_1_2_27_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(86)90625-8"},{"key":"e_1_2_27_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19871215)60:12<3020::AID-CNCR2820601227>3.0.CO;2-0"},{"key":"e_1_2_27_19_1","doi-asserted-by":"publisher","DOI":"10.1097\/00043426-200302000-00006"},{"key":"e_1_2_27_20_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jid.5700808"},{"key":"e_1_2_27_21_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI107362"},{"key":"e_1_2_27_22_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI112088"},{"key":"e_1_2_27_23_1","doi-asserted-by":"publisher","DOI":"10.1006\/mgme.2000.3034"},{"key":"e_1_2_27_24_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.fpc.0000114761.78957.7e"},{"key":"e_1_2_27_25_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdf322"},{"key":"e_1_2_27_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2007.03.028"},{"key":"e_1_2_27_27_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.08.047"},{"key":"e_1_2_27_28_1","doi-asserted-by":"publisher","DOI":"10.1097\/00043426-200403000-00004"},{"key":"e_1_2_27_29_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-04-150870"},{"key":"e_1_2_27_30_1","first-page":"1113","article-title":"Folate cycle gene variants and chemotherapy toxicity in pediatric patients with acute lymphoblastic leukemia","volume":"91","author":"Costea I.","year":"2006","journal-title":"Haematologica"},{"key":"e_1_2_27_31_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780391203"},{"key":"e_1_2_27_32_1","doi-asserted-by":"publisher","DOI":"10.1097\/MPH.0b013e3181868570"},{"key":"e_1_2_27_33_1","doi-asserted-by":"publisher","DOI":"10.1097\/00008571-200411000-00004"},{"key":"e_1_2_27_34_1","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/9.19.2837"},{"key":"e_1_2_27_35_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404495"},{"key":"e_1_2_27_36_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-09-110593"},{"key":"e_1_2_27_37_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198602203140803"},{"key":"e_1_2_27_38_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199802193380803"},{"key":"e_1_2_27_39_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1997.15.4.1560"},{"key":"e_1_2_27_40_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.mph.0000212972.90877.28"},{"key":"e_1_2_27_41_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428190701824569"},{"key":"e_1_2_27_42_1","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1124\/mol.52.1.155","article-title":"Differences in folylpolyglutamate synthetase and dihydrofolate reductase expression in human B\u2010lineage versus T\u2010lineage leukemic lymphoblasts: mechanisms for lineage differences in methotrexate polyglutamylation and cytotoxicity","volume":"52","author":"Galpin A.J.","year":"1997","journal-title":"Molecular Pharmacology"},{"key":"e_1_2_27_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0162-3109(00)00189-2"},{"key":"e_1_2_27_44_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002800050672"},{"key":"e_1_2_27_45_1","doi-asserted-by":"publisher","DOI":"10.1097\/00003086-200105000-00004"},{"key":"e_1_2_27_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/0163-7258(85)90083-X"},{"key":"e_1_2_27_47_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199610033351408"},{"key":"e_1_2_27_48_1","first-page":"1952","article-title":"A novel single\u2010nucleotide polymorphism in the 3\u2032\u2010untranslated region of the human dihydrofolate reductase gene with enhanced expression","volume":"7","author":"Goto Y.","year":"2001","journal-title":"Clinical Cancer Research"},{"key":"e_1_2_27_49_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.33.8.1032"},{"key":"e_1_2_27_50_1","doi-asserted-by":"publisher","DOI":"10.1002\/mpo.10231"},{"key":"e_1_2_27_51_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.20442"},{"key":"e_1_2_27_52_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0773.1985.tb01297.x"},{"key":"e_1_2_27_53_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.fpc.0000172242.19675.33"},{"key":"e_1_2_27_54_1","doi-asserted-by":"publisher","DOI":"10.1247\/csf.20.191"},{"key":"e_1_2_27_55_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2008.66"},{"key":"e_1_2_27_56_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10038-006-0096-z"},{"key":"e_1_2_27_57_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002800050405"},{"key":"e_1_2_27_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-291X(75)80439-6"},{"key":"e_1_2_27_59_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI108308"},{"key":"e_1_2_27_60_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19850915)56:6<1356::AID-CNCR2820560623>3.0.CO;2-H"},{"key":"e_1_2_27_61_1","first-page":"61","article-title":"Biochemical and pharmacologic rationale for high\u2010dose methotrexate","volume":"5","author":"Jolivet J.","year":"1987","journal-title":"NCI Monographs"},{"key":"e_1_2_27_62_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198311033091805"},{"key":"e_1_2_27_63_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI22477"},{"key":"e_1_2_27_64_1","first-page":"S18","article-title":"Folate and antifolate pharmacology","volume":"24","author":"Kamen B.","year":"1997","journal-title":"Seminars in Oncology"},{"key":"e_1_2_27_65_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1989.363"},{"key":"e_1_2_27_66_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.07.056"},{"key":"e_1_2_27_67_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-10-054528"},{"key":"e_1_2_27_68_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.2008.01128.x"},{"key":"e_1_2_27_69_1","first-page":"1","article-title":"Little dose, huge toxicity: profound hematological toxicity of intrathecal methotrexate","volume":"2","author":"Kose F.","year":"2009","journal-title":"Leukaemia & Lymphoma"},{"key":"e_1_2_27_70_1","doi-asserted-by":"publisher","DOI":"10.1517\/14622416.5.7.819"},{"key":"e_1_2_27_71_1","first-page":"802","article-title":"Polymorphisms in genes encoding drugs and xenobiotic metabolizing enzymes, DNA repair enzymes, and response to treatment of childhood acute lymphoblastic leukemia","volume":"8","author":"Krajinovic M.","year":"2002","journal-title":"Clinical Cancer Research"},{"key":"e_1_2_27_72_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.tpj.6500224"},{"key":"e_1_2_27_73_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-06-1794"},{"key":"e_1_2_27_74_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.tpj.6500332"},{"key":"e_1_2_27_75_1","first-page":"353","article-title":"Thymidylate synthase gene polymorphism and its association with relapse in childhood B\u2010cell precursor acute lymphoblastic leukemia","volume":"88","author":"Lauten M.","year":"2003","journal-title":"Haematologica"},{"key":"e_1_2_27_76_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V100.10.3832"},{"key":"e_1_2_27_77_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-07-0156"},{"key":"e_1_2_27_78_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1998.16.5.1712"},{"key":"e_1_2_27_79_1","doi-asserted-by":"publisher","DOI":"10.1592\/phco.25.5.748.63584"},{"key":"e_1_2_27_80_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI118409"},{"key":"e_1_2_27_81_1","first-page":"181","article-title":"Genetic tests for predicting the toxicity and efficacy of anticancer chemotherapy","volume":"54","author":"Mladosievicova B.","year":"2007","journal-title":"Neoplasma"},{"key":"e_1_2_27_82_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428190600942769"},{"key":"e_1_2_27_83_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2403484"},{"key":"e_1_2_27_84_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2402990"},{"key":"e_1_2_27_85_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.21378"},{"key":"e_1_2_27_86_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-007-0274-x"},{"key":"e_1_2_27_87_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2008.11.030"},{"key":"e_1_2_27_88_1","first-page":"4418","article-title":"The reversal of methotrexate cytotoxicity to mouse bone marrow cells by leucovorin and nucleosides","volume":"36","author":"Pinedo H.M.","year":"1976","journal-title":"Cancer Research"},{"key":"e_1_2_27_89_1","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2006.1.142"},{"key":"e_1_2_27_90_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(08)70070-6"},{"key":"e_1_2_27_91_1","doi-asserted-by":"publisher","DOI":"10.2217\/14622416.9.4.439"},{"key":"e_1_2_27_92_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clpt.2006.08.012"},{"key":"e_1_2_27_93_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V93.9.2817"},{"key":"e_1_2_27_94_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.11.020"},{"key":"e_1_2_27_95_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-04-1057"},{"key":"e_1_2_27_96_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2006.05.016"},{"key":"e_1_2_27_97_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-11-4544"},{"key":"e_1_2_27_98_1","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S0308-2261(21)00112-0","article-title":"Absorption and malabsorption of folates","volume":"5","author":"Rosenberg I.H.","year":"1976","journal-title":"Clinics in Haematology"},{"key":"e_1_2_27_99_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2401098"},{"key":"e_1_2_27_100_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0027-5107(03)00014-9"},{"key":"e_1_2_27_101_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(84)90685-3"},{"key":"e_1_2_27_102_1","doi-asserted-by":"publisher","DOI":"10.3109\/08880019109028803"},{"key":"e_1_2_27_103_1","first-page":"510","article-title":"Maintenance chemotherapy of acute lymphoblastic leukemia in children","volume":"45","author":"Schmiegelow K.","year":"1998","journal-title":"Danish Medical Bulletin"},{"key":"e_1_2_27_104_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2401986"},{"key":"e_1_2_27_105_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00694341"},{"key":"e_1_2_27_106_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1995.13.2.345"},{"key":"e_1_2_27_107_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.04.039"},{"key":"e_1_2_27_108_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00273386"},{"key":"e_1_2_27_109_1","doi-asserted-by":"publisher","DOI":"10.3109\/08880018609031223"},{"key":"e_1_2_27_110_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00256175"},{"key":"e_1_2_27_111_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00257363"},{"key":"e_1_2_27_112_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-005-0072-2"},{"key":"e_1_2_27_113_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.mph.0000198269.61948.90"},{"key":"e_1_2_27_114_1","doi-asserted-by":"publisher","DOI":"10.1097\/MPH.0b013e318165b25d"},{"key":"e_1_2_27_115_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(88)90709-5"},{"key":"e_1_2_27_116_1","first-page":"1050","article-title":"Methotrexate\u2010related neurotoxicity in the treatment of childhood acute lymphoblastic leukemia","volume":"4","author":"Shuper A.","year":"2002","journal-title":"The Israel Medical Association Journal: IMAJ"},{"key":"e_1_2_27_117_1","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s00280-002-0552-1","article-title":"High\u2010dose methotrexate: on the relationship of methotrexate elimination time vs renal function and serum methotrexate levels in 1164 courses in 264 Swedish children with acute lymphoblastic leukaemia (ALL)","volume":"51","author":"Skarby T.","year":"2003","journal-title":"Cancer Chemotherapy and Pharmacology"},{"key":"e_1_2_27_118_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404404"},{"key":"e_1_2_27_119_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0050083"},{"key":"e_1_2_27_120_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-07-102525"},{"key":"e_1_2_27_121_1","doi-asserted-by":"publisher","DOI":"10.2174\/138161208784246171"},{"key":"e_1_2_27_122_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197709222971203"},{"key":"e_1_2_27_123_1","doi-asserted-by":"publisher","DOI":"10.2217\/14622416.8.2.141"},{"key":"e_1_2_27_124_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2005.09.017"},{"key":"e_1_2_27_125_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.20092"},{"key":"e_1_2_27_126_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2402428"},{"key":"e_1_2_27_127_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(87)80025-2"},{"key":"e_1_2_27_128_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-006-0175-4"},{"key":"e_1_2_27_129_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.10847"},{"key":"e_1_2_27_130_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.1.231"},{"key":"e_1_2_27_131_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9150(00)00671-7"},{"key":"e_1_2_27_132_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kem279"},{"key":"e_1_2_27_133_1","first-page":"3416","article-title":"Single nucleotide polymorphisms in the human reduced folate carrier: characterization of a high\u2010frequency G\/A variant at position 80 and transport properties of the His(27) and Arg(27) carriers","volume":"7","author":"Whetstine J.R.","year":"2001","journal-title":"Clinical Cancer Research"},{"key":"e_1_2_27_134_1","first-page":"711","article-title":"Mechanism of action of methotrexate. IV. Free intracellular methotrexate required to suppress dihydrofolate reduction to tetrahydrofolate by Ehrlich ascites tumor cells in vitro","volume":"12","author":"White J.C.","year":"1976","journal-title":"Molecular Pharmacology"},{"key":"e_1_2_27_135_1","first-page":"408","article-title":"Synthesis of methotrexate polyglutamates in L1210 murine leukemia cells","volume":"37","author":"Whitehead V.M.","year":"1977","journal-title":"Cancer Research"},{"key":"e_1_2_27_136_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2402165"},{"key":"e_1_2_27_137_1","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/sj.leu.2403703","article-title":"Accumulation of methotrexate and methotrexate polyglutamates in lymphoblasts and treatment outcome in children with B\u2010progenitor\u2010cell acute lymphoblastic leukemia: a Pediatric Oncology Group study","volume":"19","author":"Whitehead V.M.","year":"2005","journal-title":"Leukemia"},{"key":"e_1_2_27_138_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keh088"},{"key":"e_1_2_27_139_1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.11-6-694"},{"key":"e_1_2_27_140_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1997.15.5.2125"},{"key":"e_1_2_27_141_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.061408298"},{"key":"e_1_2_27_142_1","doi-asserted-by":"publisher","DOI":"10.1006\/mgme.1999.2879"},{"key":"e_1_2_27_143_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00252965"},{"key":"e_1_2_27_144_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/84.4.252"},{"key":"e_1_2_27_145_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1993.11.5.827"},{"key":"e_1_2_27_146_1","doi-asserted-by":"publisher","DOI":"10.1517\/14740338.7.2.147"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2141.2009.07765.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2141.2009.07765.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T11:23:10Z","timestamp":1697455390000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2141.2009.07765.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8,11]]},"references-count":145,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["10.1111\/j.1365-2141.2009.07765.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2141.2009.07765.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,8,11]]},"assertion":[{"value":"2009-08-11","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}